What causes bacterial pneumonia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Bacterial Pneumonia

Streptococcus pneumoniae is the most common bacterial cause of community-acquired pneumonia (CAP), followed by Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and atypical pathogens such as Mycoplasma pneumoniae and Chlamydia pneumoniae. 1

Common Bacterial Pathogens in Community-Acquired Pneumonia

Primary Bacterial Pathogens

  • Streptococcus pneumoniae is consistently the predominant pathogen in CAP, accounting for 10-30% of all cases 1, 2
  • Haemophilus influenzae (typically non-typeable strains) is common, especially in patients with underlying bronchopulmonary disease 1, 3
  • Moraxella catarrhalis is less common but still significant, particularly in patients with chronic lung disease 1, 4
  • Staphylococcus aureus is an important cause, especially during influenza outbreaks 1, 5
  • Atypical pathogens include:
    • Mycoplasma pneumoniae (4-39% of cases, more common in older children and young adults) 1
    • Chlamydia pneumoniae (0-20% of cases) 1
    • Legionella species (particularly Legionella pneumophila) 1, 2

Age-Related Patterns

  • In children under 5 years, viral causes predominate, though bacterial co-infection is common 1
  • In school-aged children and adolescents, S. pneumoniae remains most common, but M. pneumoniae increases in prevalence 1
  • In adults, S. pneumoniae is the leading cause across all age groups, but risk for gram-negative pathogens increases with age and comorbidities 1, 2

Nosocomial (Hospital-Acquired) Pneumonia Pathogens

Hospital-acquired pneumonia involves a different spectrum of pathogens:

  • Gram-negative bacilli are predominant, including:
    • Pseudomonas aeruginosa (16.9% of cases) 1
    • Klebsiella species (11.6%) 1
    • Enterobacter species (9.4%) 1
    • Escherichia coli 1
    • Serratia marcescens 1
  • Gram-positive bacteria:
    • Staphylococcus aureus (12.9% of cases), including methicillin-resistant strains (MRSA) 1, 4

Risk Factors and Pathogenesis

Pathogenesis

  • Most bacterial pneumonias occur through aspiration of bacteria colonizing the oropharynx or upper gastrointestinal tract 1
  • Intubation and mechanical ventilation significantly increase the risk by altering first-line patient defenses 1
  • Some pathogens like Legionella species are acquired through inhalation of contaminated aerosols 1

Risk Factors for Specific Pathogens

  • Chronic obstructive pulmonary disease (COPD) increases risk for H. influenzae and M. catarrhalis 1, 4
  • Recent hospitalization increases risk for gram-negative bacilli and S. aureus 1
  • Alcoholism increases risk for Klebsiella pneumoniae and aspiration pneumonia 1
  • HIV infection increases risk for S. pneumoniae, H. influenzae, and P. aeruginosa 1, 3
  • Influenza infection predisposes to secondary bacterial pneumonia, particularly S. aureus and S. pneumoniae 1

Special Populations

Immunocompromised Hosts

  • HIV-infected individuals have higher rates of bacterial pneumonia with S. pneumoniae and H. influenzae being most common 1, 3
  • In advanced HIV disease, P. aeruginosa and S. aureus become more prevalent 1, 3
  • Risk factors for bacterial pneumonia in HIV patients include low CD4+ count, injection drug use, and cigarette smoking 1

Children

  • Viral causes predominate in younger children, with bacterial co-infection common 1
  • S. pneumoniae remains the most common bacterial cause across all pediatric age groups 1
  • Mixed viral-bacterial infections account for 8-40% of pediatric CAP cases 1

Diagnostic Considerations

  • The pathogen is not identified in 20-60% of CAP cases despite comprehensive testing 1
  • Blood or pleural fluid cultures of S. pneumoniae are positive in only 5-10% of cases 1
  • Newer molecular techniques like PCR and host transcriptional signatures are improving pathogen identification 6
  • Mixed infections (viral-bacterial or multiple bacterial pathogens) are common, occurring in 8-40% of cases 1

Clinical Implications

  • Understanding the likely pathogens based on patient factors (age, comorbidities, setting) is crucial for appropriate empiric antibiotic selection 1
  • The increasing prevalence of drug-resistant S. pneumoniae is a significant concern and is associated with increased mortality 1
  • Prevention strategies include pneumococcal vaccination, particularly in high-risk groups 3
  • Bacterial pneumonia may accelerate the progression of underlying diseases like HIV 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Prospective study of community-acquired pneumonia of bacterial etiology in adults.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1999

Research

Bacterial pneumonia.

Seminars in respiratory infections, 1999

Research

Emerging pathogens in nosocomial pneumonia.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1989

Research

Infectious pneumonias: a review.

The Journal of family practice, 1977

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.